OTC Glucose Monitors Make Wellness Tracking More Personal — and More Complicated

## Executive summary The article explains the emergence of over-the-counter continuous glucose monitors (CGMs) cleared by the FDA, outlines who may benefit (people with diabetes or prediabetes), and emphasizes that these devices provide feedback rather than medical guidance. It also highlights the app and cloud layer risks—privacy, data-sharing, HIPAA/FTC scope, and regulatory security guidance—and recommends users check FDA clearance and understand how their glucose data is used before making medical decisions.